„Enthusiast meets the Experienced“: Pneumo meets … Rheumatologie
暂无分享,去创建一个
[1] M. Humbert,et al. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. , 2022, European heart journal.
[2] F. Martinez,et al. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline , 2022, American journal of respiratory and critical care medicine.
[3] M. Kreuter,et al. Entwicklung und Fortschritt bei interstitiellen Lungenerkrankungen , 2022, Wiener klinisches Magazin.
[4] L. Mouthon,et al. Treatment of relapsing polychondritis: a systematic review. , 2021, Clinical and experimental rheumatology.
[5] H. Schäfers,et al. Chronic Thromboembolic Pulmonary Hypertension in Patients with Antiphospholipid Syndrome: Risk Factors and Management , 2021, The Journal of Heart and Lung Transplantation.
[6] K. Oniszh,et al. Dominating Cause of Pulmonary Hypertension May Change Over Time—Diagnostic and Therapeutic Considerations in a Patient with Pulmonary Hypertension Due to Rheumatoid Arthritis with Lung Involvement , 2021, Diagnostics.
[7] A. Krause,et al. Therapie von Lungenfibrosen bei rheumatischen Systemerkrankungen (neue Therapien) , 2021, Zeitschrift für Rheumatologie.
[8] M. Kreuter,et al. Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study , 2021, Thorax.
[9] P. Dieudé,et al. Baricitinib and the Risk of Incident Interstitial Lung Disease: A Descriptive Clinical Case Report from Clinical Trials , 2021, Rheumatology and Therapy.
[10] C. Heussel,et al. The Diagnosis and Treatment of Pulmonary Fibrosis. , 2021, Deutsches Arzteblatt international.
[11] J. Goldin,et al. Tocilizumab Prevents Progression of Early Systemic Sclerosis–Associated Interstitial Lung Disease , 2021, Arthritis & rheumatology.
[12] M. Gatto,et al. Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren’s syndrome: a literature review , 2021, Therapeutic advances in musculoskeletal disease.
[13] C. Denton,et al. Rituximab for the treatment of systemic sclerosis-interstitial lung disease. , 2020, Rheumatology.
[14] S. Castañeda,et al. Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients. , 2020, Rheumatology.
[15] M. Nikpour,et al. Cancer and scleroderma: recent insights , 2020, Current opinion in rheumatology.
[16] L. Czirják,et al. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database , 2020, Annals of the Rheumatic Diseases.
[17] A. Krause,et al. Lungenmanifestationen rheumatischer Erkrankungen schon früh mitbedenken , 2020, Pneumo News.
[18] J. Park,et al. Incidence Rates of Interstitial Lung Disease Events in Tofacitinib-Treated Rheumatoid Arthritis Patients , 2020, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[19] M. Kreuter,et al. The need for a holistic approach for SSc-ILD – achievements and ambiguity in a devastating disease , 2020, Respiratory Research.
[20] J. Alves,et al. Connective tissue disease-associated interstitial lung disease. , 2020, Pulmonology.
[21] B. Griffiths,et al. The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements. , 2020, The Lancet. Rheumatology.
[22] K. Liao,et al. Rheumatoid arthritis increases the risk of pleural empyema , 2020, Open medicine.
[23] Ø. Molberg,et al. Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort. , 2019, American journal of respiratory and critical care medicine.
[24] M. Leandro,et al. The lung in a cohort of rheumatoid arthritis patients-an overview of different types of involvement and treatment. , 2019, Rheumatology.
[25] T. Maher,et al. Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease , 2019, Expert review of clinical immunology.
[26] M. Revel,et al. Tracheobronchial involvement of relapsing polychondritis. , 2019, Autoimmunity reviews.
[27] M. Dougados,et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases , 2019, Annals of the rheumatic diseases.
[28] M. Kreuter,et al. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management , 2019, Current medical research and opinion.
[29] Yao Huang,et al. Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon? , 2019, Drug design, development and therapy.
[30] T. Welte,et al. Pleural Effusion in Adults-Etiology, Diagnosis, and Treatment. , 2019, Deutsches Arzteblatt international.
[31] G. Raghu,et al. Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease. , 2019, The New England journal of medicine.
[32] D. Walsh,et al. Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts , 2019, BMJ Open.
[33] V. Cottin,et al. Lung Diseases in Inflammatory Myopathies , 2019, Seminars in Respiratory and Critical Care Medicine.
[34] J. Coghlan,et al. Pulmonary Hypertension Associated with Connective Tissue Disease , 2019, Seminars in Respiratory and Critical Care Medicine.
[35] P. Merkel,et al. Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis. , 2019, Rheumatology.
[36] D. Khanna,et al. Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features , 2019, RMD Open.
[37] D. Lynch,et al. Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease–Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities , 2019, Arthritis & rheumatology.
[38] V. Cottin,et al. Treatment of idiopathic inflammatory myositis associated interstitial lung disease: A systematic review and meta-analysis. , 2019, Autoimmunity reviews.
[39] L. Flores-Suárez,et al. Frequency, treatment, evolution, and factors associated with the presence of tracheobronchial stenoses in granulomatosis with polyangiitis. Retrospective analysis of a case series from a single respiratory referral center. , 2019, Seminars in arthritis and rheumatism.
[40] R. Takei,et al. Radiological fibrosis score is strongly associated with worse survival in rheumatoid arthritis-related interstitial lung disease , 2019, Modern rheumatology.
[41] S. Birring,et al. Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial. , 2018, The Lancet. Respiratory medicine.
[42] Z. Jing,et al. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis. , 2018, Autoimmunity reviews.
[43] Christie M. Bartels,et al. Pulmonary manifestations in late versus early systemic lupus erythematosus: A systematic review and meta-analysis. , 2018, Seminars in arthritis and rheumatism.
[44] A. Tincani,et al. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome. , 2018, Blood.
[45] J. Roscamp,et al. Relapsing polychondritis: a clinical review for rheumatologists. , 2018, Rheumatology.
[46] Y. Yamaguchi,et al. Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients , 2018, Rheumatology.
[47] E. V. van Daalen,et al. Antineutrophil cytoplasmic antibody-associated vasculitis and malignancy , 2018, Current opinion in rheumatology.
[48] M. Kreuter,et al. Palliative care in interstitial lung disease: living well. , 2017, The Lancet. Respiratory medicine.
[49] C. Koegelenberg,et al. Recurrent Pulmonary Aneurysms: Hughes-Stovin Syndrome on the Spectrum of Behçet Disease. , 2017, Chest.
[50] Z. Xiong,et al. [Manifestations of the connective tissue associated interstitial lung disease under high resolution computed tomography]. , 2017, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.
[51] O. Hilberg,et al. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality , 2017, Annals of the rheumatic diseases.
[52] M. Mejía,et al. Rheumatoid arthritis-related interstitial lung disease (RA-ILD): methotrexate and the severity of lung disease are associated to prognosis , 2017, Clinical Rheumatology.
[53] J. Carey,et al. Methotrexate and lung disease in rheumatoid arthritis. , 2017, Panminerva medica.
[54] J. Ryu. Faculty of 1000 evaluation for An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. , 2016 .
[55] T. Panchabhai,et al. Lymphocytic Interstitial Pneumonia. , 2016, Clinics in chest medicine.
[56] H. Lorenz,et al. Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response , 2016, Journal of Rheumatology.
[57] X. Mariette,et al. Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. , 2015, Rheumatology.
[58] D. Lynch,et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features , 2015, European Respiratory Journal.
[59] J. Gris,et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients , 2009, Annals of the rheumatic diseases.
[60] J. Ryu,et al. Predictors of diagnosis and survival in idiopathic pulmonary fibrosis and connective tissue disease-related usual interstitial pneumonia , 2014, Respiratory Research.
[61] T. Colby,et al. Usual Interstitial Pneumonia Preceding Collagen Vascular Disease: A Retrospective Case Control Study of Patients Initially Diagnosed with Idiopathic Pulmonary Fibrosis , 2014, PloS one.
[62] J. Carey,et al. Methotrexate and Lung Disease in Rheumatoid Arthritis: A Meta‐Analysis of Randomized Controlled Trials , 2014, Arthritis & rheumatology.
[63] S. Bombardieri,et al. The diagnosis and classification of mixed connective tissue disease. , 2014, Journal of autoimmunity.
[64] H. Heinzl,et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study , 2013, Annals of the rheumatic diseases.
[65] A. Fischer,et al. Interstitial lung disease in connective tissue disorders , 2012, The Lancet.
[66] J. Piette,et al. Immunosuppressants reduce venous thrombosis relapse in Behçet's disease. , 2012, Arthritis and rheumatism.
[67] J. Huggins,et al. Chylothorax and Cholesterol Pleural Effusion , 2010, Seminars in respiratory and critical care medicine.
[68] A. Wells. The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease , 2010, European Respiratory Review.
[69] H. Collard,et al. Pulmonary rehabilitation for interstitial lung disease. , 2010, Chest.
[70] K. Lewis. Cyclophosphamide versus Placebo in Scleroderma Lung Disease , 2008 .
[71] G. Alarcón,et al. Pulmonary manifestations of rheumatoid arthritis. , 2007, Seminars in respiratory and critical care medicine.
[72] Charles Thompson,et al. The need for a holistic approach , 2007 .
[73] T. Medsger,et al. Changes in causes of death in systemic sclerosis, 1972–2002 , 2007, Annals of the rheumatic diseases.
[74] Y. Shoenfeld,et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.
[75] Y. Tsunezuka,et al. Tracheobronchial Involvement in Relapsing Polychondritis , 2000, Respiration.
[76] T. Medsger,et al. Severe restrictive lung disease in systemic sclerosis. , 1994, Arthritis and rheumatism.
[77] M. Hargreaves,et al. Acute pneumonitis associated with low dose methotrexate treatment for rheumatoid arthritis: report of five cases and review of published reports. , 1992, Thorax.